Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has important implications for the safety of participants in clinical trials and the research staff caring for them and, consequently, for the trials themselves. Patients wit...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur Heart J
Huvudupphovsmän: Anker, Stefan D, Butler, Javed, Khan, Muhammad Shahzeb, Abraham, William T, Bauersachs, Johann, Bocchi, Edimar, Bozkurt, Biykem, Braunwald, Eugene, Chopra, Vijay K, Cleland, John G, Ezekowitz, Justin, Filippatos, Gerasimos, Friede, Tim, Hernandez, Adrian F, Lam, Carolyn S P, Lindenfeld, JoAnn, McMurray, John J V, Mehra, Mandeep, Metra, Marco, Packer, Milton, Pieske, Burkert, Pocock, Stuart J, Ponikowski, Piotr, Rosano, Giuseppe M C, Teerlink, John R, Tsutsui, Hiroyuki, Van Veldhuisen, Dirk J, Verma, Subodh, Voors, Adriaan A, Wittes, Janet, Zannad, Faiez, Zhang, Jian, Seferovic, Petar, Coats, Andrew J S
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2020
Ämnen:
Current Opinion
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314099/
https://ncbi.nlm.nih.gov/pubmed/32498081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehaa461
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk